Медицинская фармакология
939 статей · 43 журналов
Журналы подкатегории (43)
- American Journal of Transplantation · Elsevier (89)
- Therapies · Elsevier (87)
- Le Pharmacien Clinicien · Elsevier (85)
- Chinese Herbal Medicines · Elsevier (80)
- International Journal of Antimicrobial Agents · Elsevier (80)
- Photodiagnosis and Photodynamic Therapy · Elsevier (80)
- Molecular Therapy: Oncology · Elsevier (78)
- Clinical Therapeutics · Elsevier (68)
- HIV Medicine · Wiley (66)
- Primary Care: Clinics in Office Practice · Elsevier (38)
- Clínica e Investigación en Arteriosclerosis · Elsevier (32)
- Pharmaceutical Statistics · Wiley (30)
- Pharmacology & Therapeutics · Elsevier (27)
- Nano TransMed · Elsevier (18)
- Neuropsychopharmacology Reports · Wiley (14)
- Traditional and Kampo Medicine · Wiley (13)
- npj Breast Cancer · Springer Nature (9)
- Fundamental and Clinical Pharmacology · Wiley (8)
- Journal of Clinical Pharmacology · Wiley (8)
- npj Vaccines · Springer Nature (8)
- Human Psychopharmacology · Wiley (7)
- Clinical Pharmacology in Drug Development · Wiley (5)
- JACCP Journal of the American College of Clinical Pharmacy · Wiley (5)
- Advanced Therapeutics · Wiley (4)
- AIDS Research and Therapy · Springer Nature (0)
- Advances in Therapy · Springer Nature (0)
- Breast Cancer · Springer Nature (0)
- Chinese Journal of Integrative Medicine · Springer Nature (0)
- Clinical Drug Investigation · Springer Nature (0)
- Clinical Pharmacokinetics · Springer Nature (0)
- Current Treatment Options in Oncology · Springer Nature (0)
- Drugs · Springer Nature (0)
- Drugs - Real World Outcomes · Springer Nature (0)
- EJNMMI Radiopharmacy and Chemistry · Springer Nature (0)
- European Archives of Psychiatry and Clinical Neuroscience · Springer Nature (0)
- Inflammopharmacology · Springer Nature (0)
- Investigational New Drugs · Springer Nature (0)
- Journal of Biomedical Science · Springer Nature (0)
- Journal of Cannabis Research · Springer Nature (0)
- Orphanet Journal of Rare Diseases · Springer Nature (0)
- Pharmaceutical Medicine · Springer Nature (0)
- Targeted Oncology · Springer Nature (0)
- Trials · Springer Nature (0)
- Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network
- Medication burden and prescribing quality in older people living with HIV: Associations with quality of life
- Quality of life among older adults with HIV after switching to bictegravir‐based three‐drug or dolutegravir‐based two‐drug regimens
- Assessing the impact, barriers and facilitators of peer‐driven interventions on the prevention of mother‐to‐child transmission of HIV in low‐ and middle‐income countries: A systematic review and meta‐analysis
- HIV‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise
- Issue Information
- CROI 2026—A summary from the BHIVA CROI Working Group
- Stimuli‐Responsive Lipid‐Based Nanocarriers for Antimicrobial Therapy
- Healing and Local Tissue Response to a Microporous Annealed Particle Wound Matrix in Porcine Full‐Thickness Wounds
- Issue Information (Adv. Therap. 11/2026)
- Cold Atmospheric Plasma for Breast Cancer Therapy: Mechanisms, Preclinical Evidence, and Translational Challenges
- Estimands for Randomized Discontinuation Designs in Oncology
- Physiologically Based Pharmacokinetic Modeling to Predict the Exposure and Provide Dosage Regimens of Oseltamivir in Pregnant Women with Comorbid CES1 Polymorphism and Hepatic Cirrhosis
- Population Pharmacokinetic and Pharmacodynamic Model of Propofol in Patients With Chronic Kidney Disease
- Integrating Omics to Advance Antiretroviral Pharmacology in Pregnancy: Dolutegravir‐Based Regimens as a Case Study
- Issue Information
- Practical Considerations for the Design, Conduct, and Reporting of Clinical Pharmacokinetic Drug–Drug Interaction Studies in Drug Development
- Issue Information
- A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants
-
Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years
Abstract Objective To compare the prevalence of comorbidity in persons with HIV ≥65 years of age based on the time from HIV diagnosis. Design Cross‐sectional observational cohort study. Methods Data was collected from 540 participants...
- Persistent Amotivation After Cannabis‐Related Psychosis: Diagnostic Challenges and Clinical Course With Electroconvulsive Therapy: A Case Report
- Correction to ‘Legal status, sex work engagement and inequities in the HIV pre‐exposure prophylaxis cascade among migrant women in 11 European countries’
- Estimation Following Surrogate Based Selection in Multi‐Arm Drop‐The‐Losers Designs
-
A UK audit of HIV partner notification and the testing of children of people living with HIV
Abstract Objectives HIV partner notification (PN) and testing of children of adults living with HIV (including adult children) are key interventions for diagnosis and linkage to care. We audited UK HIV and sexual health services'...
-
The SERAY feasibility study: Needs and barriers to HIV testing and care among women who are migrants, co‐produced with non‐governmental organizations
Abstract Objectives Women who are migrants represent a substantial proportion of new and late HIV diagnoses in Europe, yet barriers to testing and care remain poorly understood. This feasibility study aimed to identify these women's...
- Distinct Associations of Age and CYP2D6 Genotype With Parent Venlafaxine Exposure and O‐Demethylation in Japanese Psychiatric Patients
-
Enteric infections as HIV indicator conditions for HIV testing: An umbrella review
Abstract Objective The aim of this umbrella review was to explore whether faeco‐oral sexually transmissible enteric infections should be indicator conditions for HIV testing. Method Four bibliographical databases (Medline, Emcare,...
-
Weight, blood glucose and lipid changes in the course of long‐acting cabotegravir + rilpivirine: A prospective two‐year evaluation
Abstract Introduction There are little real‐world data from observational cohorts regarding the impact of long‐acting (LA) cabotegravir (CAB) and rilpivirine (RPV) treatment on weight and blood lipids. Methods This multicentre,...
- An Inverse‐Selection‐Probability Weighted Approach for Real‐World Progression‐Free Survival With Left‐Truncated Clinico‐Genomic Data
- Hepatitis delta testing and treatment cascade among people with HIV and chronic hepatitis B